Peter Reimer

4.1k total citations
46 papers, 2.2k citations indexed

About

Peter Reimer is a scholar working on Pathology and Forensic Medicine, Oncology and Dermatology. According to data from OpenAlex, Peter Reimer has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 19 papers in Oncology and 12 papers in Dermatology. Recurrent topics in Peter Reimer's work include Lymphoma Diagnosis and Treatment (23 papers), Cutaneous lymphoproliferative disorders research (12 papers) and Viral-associated cancers and disorders (8 papers). Peter Reimer is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Cutaneous lymphoproliferative disorders research (12 papers) and Viral-associated cancers and disorders (8 papers). Peter Reimer collaborates with scholars based in Germany, United States and Austria. Peter Reimer's co-authors include Florian Weißinger, Volker Kunzmann, Martin Wilhelm, Thomas Rüediger, Thomas Rüdiger, Susanne Eckstein, Hans‐Peter Tony, Eva Geissinger, Hans Konrad Müller‐Hermelink and Norbert Schmitz and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Peter Reimer

45 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Reimer Germany 22 978 916 848 396 242 46 2.2k
Jacques Bosq France 31 1.2k 1.2× 1.1k 1.3× 620 0.7× 295 0.7× 281 1.2× 74 2.5k
Luís Colomo Spain 25 1.6k 1.7× 1.9k 2.1× 779 0.9× 428 1.1× 165 0.7× 66 2.7k
Bjørn Østenstad Norway 28 1.5k 1.6× 969 1.1× 602 0.7× 245 0.6× 228 0.9× 60 2.6k
Monica Tani Italy 26 819 0.8× 1.7k 1.8× 387 0.5× 292 0.7× 385 1.6× 105 2.2k
Andreas Zettl Germany 30 1.1k 1.2× 1.3k 1.4× 490 0.6× 481 1.2× 357 1.5× 72 2.7k
Ayoma D. Attygalle United Kingdom 22 885 0.9× 1.3k 1.4× 469 0.6× 407 1.0× 110 0.5× 83 2.0k
J P Sloane United Kingdom 22 706 0.7× 730 0.8× 388 0.5× 300 0.8× 145 0.6× 34 1.9k
Kay M. Ristow United States 31 1.7k 1.7× 1.8k 2.0× 616 0.7× 161 0.4× 338 1.4× 76 2.9k
J. Bosq France 28 1.2k 1.3× 1.3k 1.5× 560 0.7× 475 1.2× 252 1.0× 70 2.8k
Martin Erlanson Sweden 25 1.2k 1.2× 1.4k 1.5× 543 0.6× 289 0.7× 364 1.5× 67 2.3k

Countries citing papers authored by Peter Reimer

Since Specialization
Citations

This map shows the geographic impact of Peter Reimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Reimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Reimer more than expected).

Fields of papers citing papers by Peter Reimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Reimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Reimer. The network helps show where Peter Reimer may publish in the future.

Co-authorship network of co-authors of Peter Reimer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Reimer. A scholar is included among the top collaborators of Peter Reimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Reimer. Peter Reimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerding, Wanda M., Thomas Mika, Matthias Eckhardt, et al.. (2022). Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients. International Journal of Cancer. 150(12). 1998–2011. 42 indexed citations
2.
Brodmann, Marianne, Martin Werner, Dirk-Roelfs Meyer, et al.. (2018). Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon. JACC: Cardiovascular Interventions. 11(23). 2357–2364. 52 indexed citations
3.
Wilhelm, Martin, Manfred Smetak, Peter Reimer, et al.. (2016). First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation. Blood Cancer Journal. 6(7). e452–e452. 50 indexed citations
4.
Schmitz, Norbert, Maike Nickelsen, Bettina Altmann, et al.. (2015). Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial.. Journal of Clinical Oncology. 18 indexed citations
5.
Reimer, Peter. (2015). New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat. Cancer Management and Research. 7. 145–145. 9 indexed citations
6.
Reimer, Peter & Shanta Chawla. (2013). Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral t-cell lymphoma. Journal of Hematology & Oncology. 6(1). 69–69. 16 indexed citations
7.
Geissinger, Eva, Peter J. Sadler, Sabine Roth, et al.. (2010). Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations. Haematologica. 95(10). 1697–1704. 43 indexed citations
8.
Bonzheim, Irina, Eva Geissinger, Wen‐Yu Chuang, et al.. (2008). Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas. Journal of Hematopathology. 1(1). 11–21. 11 indexed citations
9.
Bonzheim, Irina, Eva Geissinger, Marianne Tinguely, et al.. (2008). Evaluation of FoxP3 Expression in Peripheral T-Cell Lymphoma. American Journal of Clinical Pathology. 130(4). 613–619. 21 indexed citations
10.
11.
Geissinger, Eva, Irina Bonzheim, László Krenács, et al.. (2006). Nodal peripheral T‐cell lymphomas correspond to distinct mature T‐cell populations. The Journal of Pathology. 210(2). 172–180. 13 indexed citations
12.
Reimer, Peter & M. Hentrich. (2006). Periphere T-Zell-Lymphome - Diagnostik und Therapie. DMW - Deutsche Medizinische Wochenschrift. 131(13). 685–690. 1 indexed citations
13.
Reimer, Peter, Thomas Rüdiger, & Martin Wilhelm. (2006). The Role of High-Dose Therapy in Peripheral T-Cell Lymphomas. Clinical Lymphoma & Myeloma. 6(5). 373–379. 4 indexed citations
14.
15.
Geissinger, Eva, Seung‐Sook Lee, Irina Bonzheim, et al.. (2004). Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert?s) variant are often derived from CD8+ cytotoxic T-cells. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 445(4). 334–343. 49 indexed citations
16.
Reimer, Peter, Volker Kunzmann, Martin Wilhelm, et al.. (2003). Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT). Annals of Hematology. 82(5). 263–270. 23 indexed citations
17.
Kraemer, Doris, Florian Weißinger, Peter Reimer, et al.. (2003). Female Patient with a History of Hashimoto’s Thyroiditis, Diagnosed with MALT Lymphoma of Both Breasts. Oncology Research and Treatment. 26(3). 277–280. 3 indexed citations
18.
Weißinger, Florian, et al.. (2003). Gene transfer in purified human hematopoietic peripheral-blood stem cells by means of electroporation without prestimulation. Journal of Laboratory and Clinical Medicine. 141(2). 138–149. 17 indexed citations
19.
Reimer, Peter, et al.. (1994). Pancreatic receptors: initial feasibility studies with a targeted contrast agent for MR imaging.. Radiology. 193(2). 527–531. 37 indexed citations
20.
Haverich, Axel, et al.. (1991). Growth of Lung Allografts After Experimental Transplantation. The Thoracic and Cardiovascular Surgeon. 39(1). 40–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Bosq Breakdown of academic impact, for papers by Luís Colomo Breakdown of academic impact, for papers by Bjørn Østenstad Breakdown of academic impact, for papers by Monica Tani Breakdown of academic impact, for papers by Andreas Zettl Breakdown of academic impact, for papers by Ayoma D. Attygalle Breakdown of academic impact, for papers by J P Sloane Breakdown of academic impact, for papers by Kay M. Ristow Breakdown of academic impact, for papers by J. Bosq Breakdown of academic impact, for papers by Martin Erlanson
Rankless by CCL
2026